NYSE
PRLB
Last Price
US $76.98
KEY FIGURES
MKT CAP
$1.8B
EPS
TTM
$1.08
PEG
TTM
0.86x
P/E
TTM
71.25x
P/S
TTM
3.36x
YIELD
0.00%
GROWTH
Revenue Y/Y
4.18%
(FY vs FY)
EBITDA Y/Y
Cash Flow (DCF)
Fair Value
Market $76.98
-56.20%
Default assumptions
EBITDA Multiple
Fair Value
Market $76.98
-69.38%
Default assumptions
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Proto Labs, Inc. cash flow to debt ratio of 1.60K% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Financial risk - Healthy cash flow growth.
Proto Labs, Inc.'s free cash flow has decreased -13.11% from $68.66M last year to $59.66M, signaling decreasing performance
Financial stability - Healthy debt to equity ratio.
Proto Labs, Inc.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
Proto Labs, Inc.'s debt has decreased relative to shareholder equity from 0.01 last year to 0.00 today, signaling strengthened financials
Financial stability - Net debt/EBITDA.
Proto Labs, Inc. has a net debt to EBITDA ratio of 0.00x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial risk - ICR.
Interest expense is not separately reported in Proto Labs, Inc.'s latest filing, so interest coverage cannot be calculated.
Financial stability - Profit margin growth.
Proto Labs, Inc.'s profit margin has increased (42.31%) in the last year from 3.31% to 4.71%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Proto Labs, Inc.'s short-term assets of $233.54M exceed its short-term liabilities of $67.00M
Decreasing performance - ROA.
Proto Labs, Inc.'s return on assets of 3.31% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Proto Labs, Inc.'s return on equity of 3.84%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
Proto Labs, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Proto Labs, Inc. had positive net income in 4.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Proto Labs, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Proto Labs, Inc. has a free cash flow yield of 3.26%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
Proto Labs, Inc.'s yearly earnings has increased 28.01% since last year from $16.59M to $21.24M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Proto Labs, Inc.'s yearly revenue has increased 6.44% since last year from $500.89M to $533.13M, signaling increasing performance
Decreasing performance - ROIC.
ROIC 3.29% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Proto Labs, Inc.'s 3-year revenue CAGR of 2.96% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Proto Labs, Inc. had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Proto Labs, Inc. had positive ROE in 4.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Proto Labs, Inc. is overvalued relative to its fair value price of 33.72 based on Discounted Cash Flow model
Overvalued - Earnings yield.
Proto Labs, Inc. has an earnings yield of 1.40%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings
Overvalued - EBITDA valuation.
Proto Labs, Inc. is overvalued relative to its fair value price of 23.57 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Proto Labs, Inc. has an EV/EBITDA ratio of 26.60x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings
Undervalued - PEG ratio value.
Proto Labs, Inc. has a PEG-ratio under 1 which is considered undervalued
Undervalued - P/B ratio.
Proto Labs, Inc. has a price-to-book ratio of 2.69x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Proto Labs, Inc. has a price-to-sales ratio of 3.36x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
3.84%
Return on equity
ROIC: 3.29%
Valuation History
68.9X
Price to Earnings
EV/EBITDA: 23.7X
Cash flow
Profit margin
-7.45%
(FY vs FY)
Cash flow Y/Y
-0.10%
(FY vs FY)
Base valuations use default assumptions. Customize in the Valuator.